Hepatic metabolism of 11-oxygenated androgens in humans: an integrated in vivo and ex vivo approach
European Journal of Endocrinology · 29.08.2025 · 193 (3) · 340-347
DOI: 10.1093/ejendo/lvaf166 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Endocrinology, online erschienen am 08.08.2025. Verfasst von Tara McDonnell und 17 weiteren Autor:innen. Beteiligte Einrichtung: Androgens in Health and Disease Research Group, Academic Division of Endocrinology, Department of Medicine, Royal College of Surgeons in Ireland, Dub…. Hauptthemen laut MEDLINE: Liver, Androgens, Polycystic Ovary Syndrome, Androstenedione. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Research Council, National Research Foundation, Health Research Board.
Abstract (Originalsprache)
Objective
Excess production of adrenal-derived 11-oxygenated androgens is observed in congenital adrenal hyperplasia, premature adrenarche, and polycystic ovary syndrome. 11-Ketotestosterone is equipotent to testosterone but does not decline with age. To date, the precise hepatic metabolism of 11-oxygenated androgens and subsequent urinary metabolite excretion have not been characterised.
Design
We employed an integrated approach combining an in vivo oral androgen challenge with an ex vivo normothermic machine liver perfusion (NMLP) model to characterise human hepatic 11-oxygenated androgen metabolism.
Methods
Women with polycystic ovary syndrome were randomised to receive 150 mg of either oral dehydroepiandrosterone or 11-ketoandrostenedione (11KA4) for 7 days (n = 10 for each), with collection of 24-hour urine samples for multi-steroid profiling by liquid chromatography-tandem mass spectrometry pre- and post-intervention. We employed human liver tissue explants (n = 3) alongside a whole human liver NMLP model (n = 3) to characterise ex vivo 11-oxygenated androgen metabolism.
Results
In ex vivo studies, the main metabolites identified were 11β-hydroxyandrosterone and 11β-hydroxyetiocholanolone. In vivo priming of the 11-oxygenated pathway with oral 11KA4 resulted in significant increases of urinary 11β-hydroxyandrosterone, 11β-hydroxyetiocholanolone, and 11-ketoetiocholanolone, all known to overlap with glucocorticoid metabolism. In addition, we observed significant increases in the urinary excretion of 11-ketoandrosterone (11KAn).
Conclusions
Using in vivo and ex vivo approaches, we report the predominance of 11β-hydroxy metabolites, highlighting the pivotal role of hepatic 11β-hydroxysteroid dehydrogenase type 1 (HSD11B1) activity in 11-oxygenated androgen metabolism. We identify 11KAn as the only metabolite without overlap with glucocorticoid metabolism, underscoring its specificity and biomarker potential. NMLP represents a novel integrated model to study human hepatic steroid metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Androgens in Health and Disease Research Group, Academic Division of Endocrinology, Department of Medicine, Royal College of Surgeons in Ireland, Dublin D09 V2N0, Ireland.
- Department of Endocrinology, Beaumont Hospital, Dublin D09 V2N0, Ireland.
- Department of Metabolism and Systems Science, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, United Kingdom.
- Medical Research Council Laboratory of Medical Sciences, London W12 0HS, United Kingdom.
- Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, Institute of Biomedical Research, University of Birmingham, Birmingham B15 2TT, United Kingdom.
- Department of Surgery, RCSI University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.
ORCID-Profile: Tara McDonnell, Karl-Heinz Storbeck, Wiebke Arlt, Michael W O'Reilly
Förderung
- Medical Research Council
- National Research Foundation
- Health Research Board
- Emerging Clinician Scientist
- Wellcome Trust
Zitieren
APA
McDonnell, T., Anthony, A. V., Clarke, G., Schiffer, L., Taylor, A. E., Cussen, L., Fan, Y., Hann, A., Mao, J., Shaheen, F., Miller, C., McIlroy, M., Jacob, B., Sherlock, M., Afford, S. C., Storbeck, K. H., Arlt, W., & O'Reilly, M. W. (2025). Hepatic metabolism of 11-oxygenated androgens in humans: an integrated in vivo and ex vivo approach. European Journal of Endocrinology, 193(3), 340-347. https://doi.org/10.1093/ejendo/lvaf166
Vancouver
McDonnell T, Anthony AV, Clarke G, Schiffer L, Taylor AE, Cussen L, et al. Hepatic metabolism of 11-oxygenated androgens in humans: an integrated in vivo and ex vivo approach. European Journal of Endocrinology. 2025;193(3):340-347. doi:10.1093/ejendo/lvaf166
BibTeX
@article{McDonnell2025,
author = {McDonnell, Tara and Anthony, Amarah V and Clarke, George and Schiffer, Lina and Taylor, Angela E and Cussen, Leanne and Fan, Yiyu and Hann, Angus and Mao, Jingwen and Shaheen, Fozia and Miller, Clare and McIlroy, Marie and Jacob, Benson and Sherlock, Mark and Afford, Simon C and Storbeck, Karl-Heinz and Arlt, Wiebke and O'Reilly, Michael W},
title = {Hepatic metabolism of 11-oxygenated androgens in humans: an integrated in vivo and ex vivo approach},
journal = {European Journal of Endocrinology},
year = {2025},
volume = {193},
number = {3},
pages = {340--347},
doi = {10.1093/ejendo/lvaf166}
}
EUVIMED